The Doctors Company Expands Presence in New York Medical Malpractice Market as Admitted Insurer

September 29, 2017 by matray

The Doctors Company announced yesterday that it is now offering coverage on an admitted basis to New York healthcare providers. The New York Department of Financial Services’ recent approval of the company’s manual rate and secondary filings officially confirmed the company’s expanded presence. The Napa, Calif.-based insurer of medical liability is promising a wide variety of benefits to New York members. These benefits include risk management courses required by the state for physicians to maintain Section 18 excess eligibility, excess and primary coverage through a single carrier, coverage for both physicians and ancillary healthcare providers as well as professional and management liability policies for a variety of organizations and healthcare professionals — including medical and longterm care facilities, managed care organizations and life sciences — through its specialty lines subsidiary, TDC Specialty Underwriters.

Posted in MPL company news, Tort reform | Leave a comment
ISMIE Expands its Product and Service Lines in Missouri

September 29, 2017 by matray

ISMIE Mutual Insurance Co. and ISMIE Indemnity announced plans yesterday for expanded service and product offerings in the state of Missouri. With a recent updated rate filing, the companies will offer medical liability coverage for individual health professionals, groups and healthcare facilities. ISMIE plans to pursue new business in Missouri as a component of its national expansion plan.

“For many years, we at ISMIE have been proud to serve our Illinois policyholders who have extended their practices into the state of Missouri,” saidPaul H. DeHaan, MD, ISMIE vice chairman. “Today, we’re very pleased to offer Missouri-based professionals our entire suite of products and services that have been developed and provided over 40 years in one of the toughest medical litigation environments in America.”

Posted in MPL company news | Leave a comment